Health Policy urology

Change to Part B pay draws specialty ireSeveral medical societies, including the AUA and the American Society of Clinical Oncology, are urging congressional leaders to prevent CMS from applying MIPS adjustments to Part B drug payments.
Tax law may threaten Medicare, provider pay"Perhaps the biggest Medicare reform concern for urologists is the potential for provider reimbursements cuts, a threat that has continued to loom over the health care community for some time," writes the AACU's Ally Lopshire.
Proposed bill targets prostate cancer misdiagnosesLegislation that advocates believe would significantly reduce prostate cancer misdiagnoses is making its way through Congress and has the support of major urologic organizations and prostate cancer interest groups.
Urologists, lawmakers share experience, expertise at AACU event
Do you ‘feel the Bern’? What a single-payer system portends"While I don’t know if I 'feel the Bern' about a single-payer system, I also don’t think I would have to start looking for a second job if we transitioned to that system," writes Henry Rosevear, MD.
Survey: Urologists weigh in on MIPS, APMs, burnoutOnly one-fourth of urologists report understanding the choices available to them regarding the Merit-based Incentive Payment System and Advanced Alternative Payment Models created under Medicare’s Quality Payment Program, according to the Urology Times 2017 State of the Specialty survey.
Bill would lift Stark barriers to APMsNew legislation to modify the Stark antitrust law to remove barriers so independent physicians can take advantage of advanced payment model opportunities provided to accountable care organizations in the Affordable Care Act has been introduced with the backing of the major organizations representing urology.
MedPAC advocates for MIPS terminationIf members of the Medicare Payment Advisory Commission have their way, the new Merit-based Incentive Payment System will be sent into oblivion, never to be heard of again.
Senate takes aim at pharmacy benefit managers’ role in rising drug costsA recently proposed bill “offers transparency measures that provide stakeholders further elucidation of how money moves through the pharmaceutical supply chain,” writes the AACU’s Brian Henderson.
Statewide tests on the role of MOC multiply